[PHARMA] YoY Quarter Result on 30-Sep-2010 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
04-Nov-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Sep-2010 [#3]
Profit Trend
QoQ- -41.78%
YoY- 41.71%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Revenue 440,807 426,460 371,432 334,337 329,962 314,288 334,700 4.69%
PBT 13,461 28,493 15,646 15,405 9,427 17,641 31,915 -13.38%
Tax -9,291 -2,957 -4,687 -6,970 -3,032 -6,593 -10,354 -1.78%
NP 4,170 25,536 10,959 8,435 6,395 11,048 21,561 -23.93%
-
NP to SH 3,751 25,247 10,811 8,586 6,059 10,590 21,302 -25.11%
-
Tax Rate 69.02% 10.38% 29.96% 45.25% 32.16% 37.37% 32.44% -
Total Cost 436,637 400,924 360,473 325,902 323,567 303,240 313,139 5.69%
-
Net Worth 473,402 496,469 464,092 424,488 407,858 374,393 335,784 5.88%
Dividend
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Div 7,760 11,764 - - 28,903 - - -
Div Payout % 206.90% 46.60% - - 477.03% - - -
Equity
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Net Worth 473,402 496,469 464,092 424,488 407,858 374,393 335,784 5.88%
NOSH 258,689 117,646 106,933 106,924 107,049 106,969 106,937 15.84%
Ratio Analysis
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
NP Margin 0.95% 5.99% 2.95% 2.52% 1.94% 3.52% 6.44% -
ROE 0.79% 5.09% 2.33% 2.02% 1.49% 2.83% 6.34% -
Per Share
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
RPS 170.40 362.49 347.35 312.69 308.23 293.81 312.99 -9.62%
EPS 1.45 21.46 10.11 8.03 5.66 9.90 19.92 -35.35%
DPS 3.00 10.00 0.00 0.00 27.00 0.00 0.00 -
NAPS 1.83 4.22 4.34 3.97 3.81 3.50 3.14 -8.59%
Adjusted Per Share Value based on latest NOSH - 106,924
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
RPS 30.59 29.59 25.77 23.20 22.89 21.81 23.22 4.69%
EPS 0.26 1.75 0.75 0.60 0.42 0.73 1.48 -25.14%
DPS 0.54 0.82 0.00 0.00 2.01 0.00 0.00 -
NAPS 0.3285 0.3445 0.322 0.2945 0.283 0.2598 0.233 5.88%
Price Multiplier on Financial Quarter End Date
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Date 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 28/09/07 -
Price 4.82 7.55 5.90 4.98 4.09 3.24 3.27 -
P/RPS 2.83 2.08 1.70 1.59 1.33 1.10 1.04 18.13%
P/EPS 332.41 35.18 58.36 62.02 72.26 32.73 16.42 65.01%
EY 0.30 2.84 1.71 1.61 1.38 3.06 6.09 -39.42%
DY 0.62 1.32 0.00 0.00 6.60 0.00 0.00 -
P/NAPS 2.63 1.79 1.36 1.25 1.07 0.93 1.04 16.70%
Price Multiplier on Announcement Date
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Date 19/11/13 06/11/12 01/11/11 04/11/10 13/11/09 24/11/08 22/11/07 -
Price 4.72 8.25 5.90 4.92 3.93 3.35 3.42 -
P/RPS 2.77 2.28 1.70 1.57 1.28 1.14 1.09 16.80%
P/EPS 325.52 38.44 58.36 61.27 69.43 33.84 17.17 63.22%
EY 0.31 2.60 1.71 1.63 1.44 2.96 5.82 -38.63%
DY 0.64 1.21 0.00 0.00 6.87 0.00 0.00 -
P/NAPS 2.58 1.95 1.36 1.24 1.03 0.96 1.09 15.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment